bioRN Life Science Cluster
Welcome to bioRN, the science and industry innovation cluster in the Rhine-Neckar region around Heidelberg, one of Germany’s strongest biotech and life science hubs. BioRN combines all relevant innovation stakeholders in life sciences based on the constant interaction between academia, industry and public for the production, transfer and application of knowledge.
About us
Why bioRN?
The bioRN network fosters health innovations and serves its members by creating a rich translational ecosystem, while promoting, representing, and connecting regional innovation stakeholders. It aims to attract global investment and talent to the region, and also develops strategies and concepts to strengthen innovation and translation, simplifying the framework conditions for startups.
read more about usbioRN annual report 2024
short and crisp: the bioRN annual report 2024 showcases the bioRN project, introduces new members and the bioRN team.
read more about usAbout Us
Our Numbers
143
Members
Publications
17k+
50k+
EMPLOYEES IN ACADEMIA
18
Countries
BUDGET OF ACADEMIA
3,114 Bill.
6
Fields of Scouting
News / Events
Our Latest News and Upcoming Events
The life science ecosystem Rhine-Neckar is highly innovative and dynmic: whether it’s groundbreaking innovations, excellent research, success stories from our members or upcoming events: We keep you up to date!
News
Antibody that Neutralizes Inhibitory Factors Involved in Nerve Regeneration Leads to Enhanced Motor Function after Acute Spinal Cord Injury
Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers at 13 clinics in Germany, Switzerland, the Czech Republic and Spain have investigated this with promising results. For the first time, it was possible to identify patient groups that displayed a clinically relevant treatment effect. A follow-up study will start in December […]
Events
BIO International Convention
News
Common cough syrup ingredient shows promise in treating serious lung disease
EMBL scientists discover that an FDA-approved, over-the-counter cough syrup ingredient has potential to treat fibrotic lung disease. Summary A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions. Scientists from EMBL Heidelberg were part of a […]
Events
LSX World Congress
News
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
Heidelberg, Germany, 19.12.2024 – RHEACELL today received approval from the European Medicines Agency (EMA) for its blinded, multi-centric Phase-3 trial (NCT06489028) evaluating allo-APZ2-CVU in patients with chronic venous ulcers (CVU). The pivotal trial will be conducted at more than 100 sites and is expected to enroll 250 patients, starting enrollment in Europe in Q1 2025. […]
Events
bioRN Lounge featuring Peter Loskill – University of Tübingen & NMI Reutlingen
28 Jauary at 7 pm
Members
discover moreOur Members
Services
discover morebioRN Services
bioRN helps and supports you with several tools and knowledge for your growth …
